Found: 34
Select item for more details and to access through your institution.
The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02469
- By:
- Publication type:
- Article
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/ low miR-200c signature in vivo.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02459
- By:
- Publication type:
- Article
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 11, p. 1, doi. 10.1038/s41419-021-04262-x
- By:
- Publication type:
- Article
Nutritional Niches of Cancer Therapy-Induced Senescent Cells.
- Published in:
- Nutrients, 2022, v. 14, n. 17, p. 3636, doi. 10.3390/nu14173636
- By:
- Publication type:
- Article
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A.
- Published in:
- Nutrients, 2019, v. 11, n. 7, p. 1656, doi. 10.3390/nu11071656
- By:
- Publication type:
- Article
Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.620641
- By:
- Publication type:
- Article
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9986, doi. 10.3390/ijms23179986
- By:
- Publication type:
- Article
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7737, doi. 10.3390/ijms21207737
- By:
- Publication type:
- Article
Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7661, doi. 10.3390/ijms21207661
- By:
- Publication type:
- Article
Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1606, doi. 10.3390/ijms20071606
- By:
- Publication type:
- Article
Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 11, p. 2263, doi. 10.3390/ijms18112263
- By:
- Publication type:
- Article
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation.
- Published in:
- Frontiers in Endocrinology, 2018, p. N.PAG, doi. 10.3389/fendo.2018.00657
- By:
- Publication type:
- Article
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 479, doi. 10.1002/1878-0261.13582
- By:
- Publication type:
- Article
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22101-7
- By:
- Publication type:
- Article
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT).
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047599
- By:
- Publication type:
- Article
The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027206
- By:
- Publication type:
- Article
Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019527
- By:
- Publication type:
- Article
olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors.
- Published in:
- Carcinogenesis, 2019, v. 40, n. 1, p. 27, doi. 10.1093/carcin/bgy159
- By:
- Publication type:
- Article
Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells.
- Published in:
- Carcinogenesis, 2018, v. 39, n. 4, p. 601, doi. 10.1093/carcin/bgy023
- By:
- Publication type:
- Article
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. 9, p. 1381, doi. 10.1177/0269881109354926
- By:
- Publication type:
- Article
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00193
- By:
- Publication type:
- Article
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6214, doi. 10.3390/cancers14246214
- By:
- Publication type:
- Article
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6101, doi. 10.3390/cancers14246101
- By:
- Publication type:
- Article
Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4168, doi. 10.3390/cancers13164168
- By:
- Publication type:
- Article
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4009, doi. 10.3390/cancers13164009
- By:
- Publication type:
- Article
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1132, doi. 10.3390/cancers13051132
- By:
- Publication type:
- Article
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1757, doi. 10.3390/cancers12071757
- By:
- Publication type:
- Article
A multiscale model of epigenetic heterogeneity-driven cell fate decision-making.
- Published in:
- PLoS Computational Biology, 2019, v. 15, n. 4, p. 1, doi. 10.1371/journal.pcbi.1006592
- By:
- Publication type:
- Article
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2180, doi. 10.3390/jcm8122180
- By:
- Publication type:
- Article
EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
- Published in:
- Oncology Reports, 2017, v. 38, n. 1, p. 263, doi. 10.3892/or.2017.5682
- By:
- Publication type:
- Article
Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model.
- Published in:
- PLoS Computational Biology, 2018, v. 14, n. 3, p. 1, doi. 10.1371/journal.pcbi.1006052
- By:
- Publication type:
- Article
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX.
- Published in:
- Aging Cell, 2018, v. 17, n. 4, p. 1, doi. 10.1111/acel.12772
- By:
- Publication type:
- Article
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 1, p. 19, doi. 10.3390/ph15010019
- By:
- Publication type:
- Article
Lung Cancer Management with Silibinin: A Historical and Translational Perspective.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 6, p. 559, doi. 10.3390/ph14060559
- By:
- Publication type:
- Article